Act for the Development of Biotech and Pharmaceutical Industry Article 14

To expedite the review and approval of new biotech and pharmaceutical products and facilitate product launch, each central competent authority in charge of the industry concerned shall establish open and transparent procedures and a unified review system for the necessary pre-market approvals, including field tests, clinical trials, product registration and others. Furthermore, these authorities shall develop professional review capabilities and refine the relevant review standards.To facilitate the R&D of biotech and pharmaceutical products and technologies, the Competent Authority and each central governmental authority in charge of the industry concerned may provide assistance in establishing testing sites for products and technologies under research and development.